210 related articles for article (PubMed ID: 15840724)
1. Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia.
Goriely A; McVean GA; van Pelt AM; O'Rourke AW; Wall SA; de Rooij DG; Wilkie AO
Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6051-6. PubMed ID: 15840724
[TBL] [Abstract][Full Text] [Related]
2. Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line.
Goriely A; McVean GA; Röjmyr M; Ingemarsson B; Wilkie AO
Science; 2003 Aug; 301(5633):643-6. PubMed ID: 12893942
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome.
Ibrahimi OA; Eliseenkova AV; Plotnikov AN; Yu K; Ornitz DM; Mohammadi M
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7182-7. PubMed ID: 11390973
[TBL] [Abstract][Full Text] [Related]
4. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand.
Anderson J; Burns HD; Enriquez-Harris P; Wilkie AO; Heath JK
Hum Mol Genet; 1998 Sep; 7(9):1475-83. PubMed ID: 9700203
[TBL] [Abstract][Full Text] [Related]
5. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome.
Wilkie AO; Slaney SF; Oldridge M; Poole MD; Ashworth GJ; Hockley AD; Hayward RD; David DJ; Pulleyn LJ; Rutland P
Nat Genet; 1995 Feb; 9(2):165-72. PubMed ID: 7719344
[TBL] [Abstract][Full Text] [Related]
6. Molecular diagnosis of Apert syndrome in Chinese patients.
Tsai FJ; Tsai CH; Peng CT; Lin SP; Hwu WL; Wang TR; Lee CC; Wu JY
Acta Paediatr Taiwan; 1999; 40(1):31-3. PubMed ID: 10910582
[TBL] [Abstract][Full Text] [Related]
7. Exclusive paternal origin of new mutations in Apert syndrome.
Moloney DM; Slaney SF; Oldridge M; Wall SA; Sahlin P; Stenman G; Wilkie AO
Nat Genet; 1996 May; 13(1):48-53. PubMed ID: 8673103
[TBL] [Abstract][Full Text] [Related]
8. A further mutation of the FGFR2 tyrosine kinase domain in mild Crouzon syndrome.
de Ravel TJ; Taylor IB; Van Oostveldt AJ; Fryns JP; Wilkie AO
Eur J Hum Genet; 2005 Apr; 13(4):503-5. PubMed ID: 15523492
[TBL] [Abstract][Full Text] [Related]
9. De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome.
Oldridge M; Zackai EH; McDonald-McGinn DM; Iseki S; Morriss-Kay GM; Twigg SR; Johnson D; Wall SA; Jiang W; Theda C; Jabs EW; Wilkie AO
Am J Hum Genet; 1999 Feb; 64(2):446-61. PubMed ID: 9973282
[TBL] [Abstract][Full Text] [Related]
10. A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis.
Chen L; Li D; Li C; Engel A; Deng CX
Bone; 2003 Aug; 33(2):169-78. PubMed ID: 14499350
[TBL] [Abstract][Full Text] [Related]
11. Mutation of the fibroblast growth factor receptor 2 gene in Japanese patients with Apert syndrome.
Matsumoto K; Urano Y; Kubo Y; Nakanishi H; Arase S
Plast Reconstr Surg; 1998 Feb; 101(2):307-11. PubMed ID: 9462761
[TBL] [Abstract][Full Text] [Related]
12. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
Britto JA; Moore RL; Evans RD; Hayward RD; Jones BM
J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
[TBL] [Abstract][Full Text] [Related]
13. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2.
Oldridge M; Lunt PW; Zackai EH; McDonald-McGinn DM; Muenke M; Moloney DM; Twigg SR; Heath JK; Howard TD; Hoganson G; Gagnon DM; Jabs EW; Wilkie AO
Hum Mol Genet; 1997 Jan; 6(1):137-43. PubMed ID: 9002682
[TBL] [Abstract][Full Text] [Related]
15. The impact of chemo- and radiotherapy treatments on selfish de novo FGFR2 mutations in sperm of cancer survivors.
Maher GJ; Bernkopf M; Koelling N; Wilkie AOM; Meistrich ML; Goriely A
Hum Reprod; 2019 Aug; 34(8):1404-1415. PubMed ID: 31348830
[TBL] [Abstract][Full Text] [Related]
16. Trp290Cys mutation in exon IIIa of the fibroblast growth factor receptor 2 (FGFR2) gene is associated with Pfeiffer syndrome.
Tartaglia M; Valeri S; Velardi F; Di Rocco C; Battaglia PA
Hum Genet; 1997 May; 99(5):602-6. PubMed ID: 9150725
[TBL] [Abstract][Full Text] [Related]
17. [Nucleotide sequences at intron 6 and exon 7 junction of fibroblast growth factor receptor 2 and rapid mutational analysis in Apert syndrome].
Wada C; Ishigaki M; Toyo-oka Y; Yamabe H; Ohnuki Y; Takada F; Yamazaki Y; Ohtani H
Rinsho Byori; 1996 May; 44(5):435-8. PubMed ID: 8676562
[TBL] [Abstract][Full Text] [Related]
18. Two common mutations 934C to G and 937C to G of fibroblast growth factor receptor 2 (FGFR2) gene in Chinese patients with Apert syndrome.
Tsai FJ; Hwu WL; Lin SP; Chang JG; Wang TR; Tsai CH
Hum Mutat; 1998; Suppl 1():S18-9. PubMed ID: 9452027
[No Abstract] [Full Text] [Related]
19. A novel heterozygous mutation of three consecutive nucleotides causing Apert syndrome in a Congolese family.
Lumaka A; Mubungu G; Mukaba P; Mutantu P; Luyeye G; Corveleyn A; Tady BP; Lukusa Tshilobo P; Devriendt K
Eur J Med Genet; 2014 Mar; 57(4):169-73. PubMed ID: 24486773
[TBL] [Abstract][Full Text] [Related]
20. FGFR2 mutation in a patient with Apert syndrome associated with humeroradial synostosis.
Kanauchi Y; Muragaki Y; Ogino T; Takahara M; Tsuchida H; Ishigaki D
Congenit Anom (Kyoto); 2003 Dec; 43(4):302-5. PubMed ID: 15041782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
